FIELD: medicine.
SUBSTANCE: invention relates to use butilidenphthalide for inhibition of motor neurons autophagy.
EFFECT: invention can be used for delay of the beginning of degenerative diseases of a motor neuron.
8 cl, 6 ex, 4 tbl, 7 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| UROKINASE INHIBITORS ADMINISTRATION FOR TREATMENT AND/OR PREVENTION OF NEUROPATHOLOGICAL DISEASES | 2006 |
|
RU2410087C2 |
| USING SEQUENCE CODING C-TERMINAL HEAVY CHAIN DOMAIN OF TETANUS TOXIN AS THERAPEUTIC AGENT | 2008 |
|
RU2495676C2 |
| NEW COMBINATIONS OF NERAMEXANE FOR TREATING NEURODEGENERATIVE DISORDERS | 2008 |
|
RU2432161C1 |
| PHARMACEUTICAL COMPOSITION AND METHOD OF THERAPY OF NEURODEGENERATIVE DISORDERS, INCLUDING AMYOTROPHIC LATERAL SCLEROSIS | 2012 |
|
RU2491097C1 |
| USE OF BENZOATE FOR TREATMENT OF DISORDERS OF CENTRAL NERVOUS SYSTEM | 2017 |
|
RU2780450C2 |
| THERAPEUTIC AGENT FOR AMYOTROPHIC LATERAL SCLEROSIS | 2013 |
|
RU2655811C2 |
| VACCINE AND METHOD FOR TREATING MOTOR NEURON DISEASES | 2002 |
|
RU2303996C2 |
| EXTRACELLULAR DNA AS A THERAPEUTIC TARGET IN NEURODEGENERATION | 2016 |
|
RU2726131C2 |
| NEW THERAPEUTIC USE OF BENZYLIDENEGUANIDINE DERIVATIVES FOR TREATING PROTEOPATHIES | 2015 |
|
RU2712452C2 |
| TREATMENT METHOD FOR AMYOTROPHIC LATERAL SCLEROSIS | 2023 |
|
RU2804196C1 |
